Soley Therapeutics
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Drug Discovery
📍 South San Francisco, CA
Founded 2020
Current Valuation
$700M
as of 2024-Q3
PRIVATE
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Company Profile
HQ
South San Francisco, CA
Last Round
Series C — $200M (Sep 2024)
Fundraising Status
Series C · $200M · 1y 9mo ago
privateTotal raised $290M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $200M | Sep 2024 | — | $700M |
Health CareBiotechnologyTherapeutics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.